Phase 3 HIV trials recruiting now

All HIV trials, every phase

Other phases for HIV

Phase 3 HIV trials

• A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
  NCT07266831 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 55 locations
• A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
  NCT07044297 · Phase: Phase 3 · Ages: 16 Years and older · Sex: All (male and female) · 81 locations
• A Continued Access Study for Participants Transitioning From ViiV Healthcare-sponsored or ViiV Healthcare-collaborative Parent Studies for HIV Treatment
  NCT07393659 · Phase: Phase 3 · Ages: No age limits stated · Sex: All (male and female) · 4 locations
• A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)
  NCT07071623 · Phase: Phase 3 · Ages: 16 Years to 30 Years · Sex: Female · 30 locations
• A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
  NCT07650916 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · 88 locations
• An Enhanced Package of Care to Reduce Reduce Mortality in Advanced HIV Disease
  NCT05085171 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Antiretroviral Therapy for Acute and Chronic HIV Infection
  NCT00796263 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
  NCT04147286 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB
  NCT06568484 · Phase: Phase 2, Phase 3 · Ages: No age limits stated · Sex: All (male and female) · 8 locations
• Cefixime Clinical Trial
  NCT04958122 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• DOR/TDF/3TC COmpared With BIC/FTC/TAF in ART-Naïve People Living With HIV and Overweight or Obesity
  NCT07075146 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment
  NCT06497465 · Phase: Phase 3 · Ages: 15 Years to 99 Years · Sex: All (male and female) · 6 locations
• Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS
  NCT05814432 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• Efficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch
  NCT04892654 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France.
  NCT05813964 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 4 locations
• Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa
  NCT04975178 · Phase: Phase 3 · Ages: 5 Minutes to 7 Days · Sex: All (male and female) · 1 location
• Evaluating Smoking Cessation Interventions for PWH in South Africa
  NCT05413122 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis
  NCT04145258 · Phase: Phase 3 · Ages: 15 Years and older · Sex: All (male and female) · 13 locations
• Long-Acting HIV Pre-Exposure Prophylaxis Integrated With Sexual and Reproductive Health - cRCT
  NCT06250504 · Phase: Phase 3 · Ages: 15 Years to 30 Years · Sex: All (male and female) · 1 location
• Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia
  NCT04851015 · Phase: Phase 3 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location
• Naltrexone for Overdose Prevention
  NCT06633900 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Ndovu RCT: Investing the Optimal Management of Dolutegravir Resistance
  NCT06747507 · Phase: Phase 3 · Ages: 3 Years and older · Sex: All (male and female) · 9 locations
• Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals
  NCT06507059 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Platform Trial For Cryptococcal Meningitis (PLATFORM-CM)
  NCT06666322 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Reducing Mortality in Adults With Advanced HIV Disease (REVIVE)
  NCT05580666 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 52 locations
• STI Testing to Enhance PrEP Use in Pregnancy
  NCT06919614 · Phase: Phase 3 · Ages: No age limits stated · Sex: Female · 1 location
• Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
  NCT07682961 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 19 locations
• The Implementation of Pre-exposure Prophylaxis of Injectable Cabotegravir
  NCT05515770 · Phase: Phase 3 · Ages: 18 Years to 30 Years · Sex: Male · 1 location
• V+PSF-M for Tobacco Cessation in HIV Care in India
  NCT05786547 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Common questions

What does Phase 3 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.